<DOC>
	<DOCNO>NCT02764073</DOCNO>
	<brief_summary>Despite impressive improvement treatment strategy , heart failure ( HF ) morbidity mortality remain substantially high worldwide . Pulmonary congestion consider leading cause hospital admission death among patient HF . Physical examination crucial titrate medical treatment patient , despite good specificity sensitive enough detect early elevate cardiac filling pressure . The N-terminal pro-B-type natriuretic peptide ( NT-proBNP ) recognize powerful predictor HF prognosis . Recently , cardiotrophin-1 galectin-3 propose new relevant biomarkers HF evaluation . Echocardiography also use noninvasively measure leave ventricular filling pressure . Lung ultrasound ( LUS ) interstitial B-line evaluation recently propose bed-side , noninvasive tool ass interstitial lung water . B-lines correlate NT-proBNP E/e ' level patient acute dyspnea , chronic HF stress test . LUS also identify clinically silent pulmonary edema , suggest may complement clinical evaluation improve hemodynamic profiling treatment optimization . Biompedance bedside method total body fluid status assessment . It define individual fluid status/compartments/overload basis individual 's normal extracellular volume body composition . Recent study indicate bioimpedance-derived fluid overload index independent predictor mortality renal failure patient . To date , study evaluate bioimpedance performance fluid assessment HF patient . The investigator aim cross-sectionally compare bioimpedance parameter clinical evaluation , LUS , cardiac biomarkers , echocardiographic characteristic , cohort incident consecutive patient HF . Two year patient ' survival evaluate propose best evaluative algorithm rank various method prognostic significance .</brief_summary>
	<brief_title>Bioimpedance Spectroscopy Evaluation Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1. age â‰¥18 year ; 2 . HF diagnosis regardless cause define Framingham criterion satisfy European Society Cardiology guideline ; 1. metallic joint prosthesis , cardiac stent pacemaker , decompensated cirrhosis , pregnancy limb amputation ( due bioimpedance technique limitation ) ; 2. prior diagnosis pulmonary fibrosis ( due lung ultrasonography limitation ) ; 3. absence congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Bioimpedance</keyword>
	<keyword>Lung ultrasonography</keyword>
</DOC>